Source link : https://www.newshealth.biz/health-news/oral-ketamine-promising-for-resistant-depression/
An extended-release oral tablet formulation of ketamine has shown promise for treatment-resistant depression (TRD) results of a phase 2 proof-of-concept study suggest. In the trial, twice weekly dosing of extended-release ketamine led to statistically significant and clinically meaningful improvement in depressive symptoms. Overall tolerability was “excellent,” researchers reported, and common side effects commonly associated with […]
Author : News Health
Publish date : 2024-06-24 18:49:30
Copyright for syndicated content belongs to the linked Source.
Categories